Pathophysiology of dry eye disease and novel therapeutic agents
SD Mathebula, L Mmusi-Landela - African Vision and Eye Health, 2024 - journals.co.za
Background Dry eye disease (DED) is one of the most common ocular surface diseases,
which is caused by decreased tear production or increased evaporation. It is a growing …
which is caused by decreased tear production or increased evaporation. It is a growing …
[PDF][PDF] Applications of Diquafosol Sodium in Ophthalmology: A Comprehensive Review on Therapeutic Utility
Diquafosol is a purinergic P2Y2 receptor agonist that is garnering much interest for its
potential therapeutic benefits in dry eye disease (DED) management and is used commonly …
potential therapeutic benefits in dry eye disease (DED) management and is used commonly …
[PDF][PDF] Dry Eye: A Hands-On Guide for Diagnosis and Treatment in Primary Care
LLC Alcon Vision - 2024 - cdn.mdedge.com
In support of improving patient care, Medscape, LLC is jointly accredited with commendation
by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation …
by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation …